DK105414C - Process for the preparation of 3,8-diazabicyclo- (3,2,1) -octanes or acid addition salts or quaternary alkylammonium halides thereof. - Google Patents

Process for the preparation of 3,8-diazabicyclo- (3,2,1) -octanes or acid addition salts or quaternary alkylammonium halides thereof.

Info

Publication number
DK105414C
DK105414C DK282462AA DK282462A DK105414C DK 105414 C DK105414 C DK 105414C DK 282462A A DK282462A A DK 282462AA DK 282462 A DK282462 A DK 282462A DK 105414 C DK105414 C DK 105414C
Authority
DK
Denmark
Prior art keywords
octanes
diazabicyclo
preparation
acid addition
addition salts
Prior art date
Application number
DK282462AA
Other languages
Danish (da)
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of DK105414C publication Critical patent/DK105414C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK282462AA 1961-06-26 1962-06-25 Process for the preparation of 3,8-diazabicyclo- (3,2,1) -octanes or acid addition salts or quaternary alkylammonium halides thereof. DK105414C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB23076/61A GB949088A (en) 1961-06-26 1961-06-26 Diazabicyclo-octane derivatives

Publications (1)

Publication Number Publication Date
DK105414C true DK105414C (en) 1966-09-26

Family

ID=10189738

Family Applications (1)

Application Number Title Priority Date Filing Date
DK282462AA DK105414C (en) 1961-06-26 1962-06-25 Process for the preparation of 3,8-diazabicyclo- (3,2,1) -octanes or acid addition salts or quaternary alkylammonium halides thereof.

Country Status (6)

Country Link
BE (1) BE618813A (en)
BR (1) BR6240334D0 (en)
CH (1) CH423799A (en)
DK (1) DK105414C (en)
FI (1) FI40096C (en)
GB (1) GB949088A (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274018B (en) * 1994-02-23 1997-07-14 Riace Ets 3,8-DIAZABICYCLE DERIVATIVES (3.2.1.) OCTANO FOR ANALGESIC ACTIVITY
SE0003795D0 (en) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
WO2006058879A1 (en) * 2004-11-30 2006-06-08 Neurosearch A/S Novel diazabicyclic aryl derivatives as cholinergy ligands
US8673920B2 (en) * 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2632465B1 (en) 2010-10-27 2015-12-30 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2632464B1 (en) 2010-10-29 2015-04-29 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013028474A1 (en) 2011-08-19 2013-02-28 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013039802A1 (en) 2011-09-16 2013-03-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013062892A1 (en) 2011-10-25 2013-05-02 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013062900A1 (en) 2011-10-25 2013-05-02 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013066717A1 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773199B1 (en) 2011-10-31 2019-04-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773351B1 (en) 2011-10-31 2017-08-23 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9206199B2 (en) 2011-12-16 2015-12-08 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (en) 2012-07-26 2015-03-18 Merck Sharp & Dohme INHIBITORS OF THE EXTERNAL RENAL MEDULAR POTASSIUM CHANNEL
EP2925322B1 (en) 2012-11-29 2018-10-24 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2934533B1 (en) 2012-12-19 2017-11-15 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2956142B1 (en) 2013-02-18 2017-09-20 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014150132A1 (en) 2013-03-15 2014-09-25 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2015017305A1 (en) 2013-07-31 2015-02-05 Merck Sharp & Dohme Corp Inhibitors of the renal outer medullary potassium channel
WO2016127358A1 (en) 2015-02-12 2016-08-18 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel

Also Published As

Publication number Publication date
FI40096C (en) 1968-10-10
BR6240334D0 (en) 1973-05-24
CH423799A (en) 1966-11-15
FI40096B (en) 1968-06-28
BE618813A (en) 1962-10-01
GB949088A (en) 1964-02-12

Similar Documents

Publication Publication Date Title
DK107029C (en) Process for the preparation of substituted 2-arylamino-1,3-diazacycloalkenes or acid addition salts thereof.
DK105414C (en) Process for the preparation of 3,8-diazabicyclo- (3,2,1) -octanes or acid addition salts or quaternary alkylammonium halides thereof.
DK114903B (en) Process for the preparation of 9,10-dihydro-ergovaline or acid addition salts thereof.
DK104460C (en) Process for the preparation of 2-methyl-3-hydroxypyridines or acid addition salts thereof.
DK103079C (en) Process for the preparation of 4-amino-quinoline compounds or acid addition salts thereof.
DK105205C (en) Process for the preparation of pyridyl or pyrazyloxyalkylaminoalkylamines or acid addition salts thereof.
DK103672C (en) Process for the preparation of phenylpropanolamines or acid addition salts thereof.
DK103941C (en) Process for the preparation of 3-thiocarbamoyl-phenthiazine compounds or acid addition salts thereof.
DK103017C (en) Process for the preparation of basic substituted dibenzocycloheptadiene or dibenzocycloheptatriene compounds or acid addition salts thereof.
DK118189B (en) Analogous process for the preparation of benzyloxyamines or acid addition salts thereof.
DK104106C (en) Process for the preparation of 5-aryl-benzodiazepine compounds or acid addition salts thereof.
DK102807C (en) Process for the preparation of substituted diphenylalkenylamines or acid addition salts thereof.
DK110091C (en) Process for the preparation of substituted diphenylalkylamines or acid addition salts thereof.
DK104299C (en) Process for the preparation of tertiary aminoalkylidene substituted dibenzocycloheptadiene, dibenzocycloheptatriene or thioxanthene compounds or acid addition salts or quaternary ammonium compounds thereof.
DK99308C (en) Process for the preparation of dihydrodibenzo- (b, e) (1,4) -thiazepine compounds or acid addition salts or quaternary ammonium compounds thereof.
DK98757C (en) Process for the preparation of dihydrodibenzo- (b, e) (1,4) -thiazepine compounds or acid addition salts or quaternary ammonium compounds thereof.
DK105156C (en) Process for the preparation of the 18,20-lactone of 3-methylamino-16α, 20-dihydroxy-5 (6) -pregnene-18-acid or the 18,20-lactone of 3-dimethylamino-16α, 20-dihydroxy-5 (6 ) -pregnen-18-acid or acid addition salts thereof.
DK103562C (en) Process for the preparation of α-cyclopentyl-benzylamines or acid addition salts or quaternary ammonium compounds thereof.
DK101743C (en) Process for the preparation of 1-aza-thioxanthene compounds or acid addition salts or quaternary ammonium compounds thereof.
DK101690C (en) Process for the preparation of 1-aza-thioxanthene compounds or acid addition salts or quaternary ammonium compounds thereof.
DK100728C (en) Process for the preparation of 1-aza-thioxanthene compounds or acid addition salts or quaternary ammonium compounds thereof.
DK99268C (en) Process for the preparation of aminobenzoxacycloalkanes or acid addition salts thereof.
DK101066C (en) Process for the preparation of dihaloaminobenzylamines or acid addition salts thereof.
DK102575C (en) Process for the preparation of N-benzodioxylurethanes or acid addition salts thereof.
DK102517C (en) Process for the preparation of dihydrodibenzocyclohetenes or acid addition salts thereof.